CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Contoura LASIKdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05848817
NCT05848817N/ACompleted
CompareCT.gov

Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software

Mann Eye Institute·observational·Posted May 8, 2023·Updated Jul 17, 2025

In Brief

An observational study evaluating Contoura LASIK for Myopia. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The objective is to determine the percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Phorcides Planned Contoura LASIK.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
CollaboratorsSengi

Timeline

N/ACompletedFinished
202420252026
First PostedMay 8, 2023
Enrollment StartMay 19, 2023
Primary CompletionAug 15, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 3.1 years ago

Interventions

Contoura LASIKdevice

Subjects receiving Phorcides Planned Contoura LASIK